摘要
从肝肾同源理论的应用出发,结合骨保护素(osteoprotegerin,OPG)/核因子受体活化因子NF-κB配体(receptor activator of NF-κB ligand,RANKL)/NF-κB受体活化因子(receptor activator for NF-κB,RANK)信号系统在骨代谢中的调控机制,阐释肝肾同源理论应用于临床的客观分子生物学依据,更好地指导临床。
Objective molecular biological evidence of applying"the same source of liver and kidney"is explained on the foundation of the application of the theory,combined with the regulatory mechanism of OPG/RANKL/RANK signaling system in bone metabolism,in order to better guide clinical prevention and treatment of bone metastasis cancer pain.
作者
李玲
李菁
LI Ling;LI Jing(Shuguang Hospital Affiliated to Shanghai University of TCM,Shanghai 201203,China;The First Hospital of Hunan University of Chinese Medicine)
出处
《西部中医药》
2022年第6期149-152,共4页
Western Journal of Traditional Chinese Medicine
基金
2018年度湖南中医药大学校级科研基金项目(2018XJJJ54)。